PharmaBoardroom

Interview with Harald Stock, CEO, Grünenthal

You arrived at Grünenthal fairly recently, in January of this year. What was it about the company that attracted you to the position? That goes back…

Interview with Sophie Kornowski-Bonnet, President, France, Roche…

Roche has a long history in France and currently enjoys a higher position than its worldwide ranking. Can you elaborate on the importance of this…

Interview with Jean-Luc Bélingard, CEO, Ipsen France

As the G5 brings together five very different companies - Ipsen, LFB, Pierre Fabre, Sanofi-Aventis, Servier - could you explain the origin behind the…

Interview with Robert Dahan, President, AstraZeneca France

You’ve been at the head of AstraZeneca France for 7 years through during which time there has been a lot of M&A activity in the industry as…

Interview with Jean-Pierre Cassan, Honrary President of the LEEM,…

Throughout your prolific career in the pharmaceutical industry, what would you describe have been the major changes in the French pharmaceutical…

Interview with André Choulika, President, France Biotech

France is a major pharmaceutical market, leader in Europe and number three in the world but it seems in biotechnologies, France lags behind. In your…

Interview with Boudewijn Van Bochove , CEO, Biogen Idec Germany

Having experienced many years at big pharmaceutical companies, you recently moved into the booming biotech sector by joining Biogen Idec in 2007. What…

Interview with Hervé Gisserot, President, GSK France

France yet today you work for a foreign multinational within France. Can you speak to the differences in culture and what the transition has been…

Interview with Philippe Lamoureux, LEEM – Les Enterprises…

What are the main tasks of the LEEM? The LEEM is the only professional organization representing the pharmaceutical industry in France. It…

Interview with Jean-Pierre Barrère, President, FPS –…

FPS is a hundred year old organization with roots in the beginning of the last century representing today SME suppliers to the health industries.…

Jean-François Dehecq – Chairman, Sanofi-Aventis

What was the idea behind the creation of the « Etats Generaux de l’industrie » (General States of Industries)? What can we expect from them?…

Interview with Wolfgang Söhngen, CEO, Paion

Why was the time right in 2000 to start Paion, and how did your background and experiences in the pharma industry, academia and consulting help you…

Tagged with A